CV9202 is also a self-adjuvanted mRNA vaccine encoding six NSCLC-associated antigens, namely NY-ESO-1, MAGE-C1, MAGE-C2, survivin, 5T4, and MUC-1, which induce targeted immune responses. Here, BIRC5 is linked to non-small cell lung carcinoma.